Xencor, Inc. (XNCR) Financials

XNCR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 952.7 million 283.6 million
2023-09-30 778.4 million 109.4 million
2023-06-30 778.1 million 99.2 million
2023-03-31 803.4 million 119.8 million

XNCR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 179.5 million 14.7 million
2023-09-30 -30.7 million 12.9 million
2023-06-30 -43.1 million 13.6 million
2023-03-31 -41.8 million 12.6 million

XNCR Net Income

No data available :(

XNCR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 593.7 million - 62.5 million
2023-09-30 494.5 million - 60.8 million
2023-06-30 551.4 million - 58.8 million
2023-03-31 588.0 million - 59.2 million

XNCR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 60.8 million
2023-09-30 60.6 million
2023-06-30 59.8 million
2023-03-31 59.8 million

XNCR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.7 million 63.0 million 15.5 million -3.4 million
2023-09-30 3.4 million 64.9 million 12.5 million -
2023-06-30 4.9 million 60.1 million 11.5 million -
2023-03-31 11.2 million 64.4 million 13.9 million -

XNCR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 44.7 million 3.2 million
2023-09-30 59.2 million 3.1 million
2023-06-30 45.5 million 2.9 million
2023-03-31 19.0 million 2.2 million

XNCR

Price: $24.11

52 week price:
16.49
30.21

Earnings Per Share: -2.08 USD

P/E Ratio: -9.33

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 500400

Ebitda: -14.8 million

Market Capitalization: 1.3 billion

Links: